- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 136.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 133.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 97.93M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $7.13M |
| Capex | Q1 2026 · Mar 31, 2025 | $4.33M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $17.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.48M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $106.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $89.46M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$172.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$131.54M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $494.52M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $386.69M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $929.94M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $794.48M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $491.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $470.68M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $757.85M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $662.94M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.60 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.60 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $44.38M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $28.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$76.95M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$22.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.66M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.84M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $170.96M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $120.83M |
| Revenue | Q1 2026 · Mar 31, 2026 | $214.41M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $148.6M |